Jasleen Kukreja, MD
Surgery · San Francisco, CANPI 1174556351
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $24,000 of the $34,422 with a category attached, or 69.7%. Transmedics, Inc. accounts for 65.4% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $22,500 and has fallen 92.1% since, to $1,781 in 2025. Among surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 26 payments — averaging $1323.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Transmedics, Inc.$23K
- United Therapeutics Corporation$5K
- Merck$3K
- Xvivo Perfusion Inc.$2K
- Sanofi-aventis U.S. LLC$1K
- Atricure, Inc.$398
- plus $546 from 5 others
Across 8 payments — averaging $34,470 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Paragonix Technologies, Inc.$171K
- Transmedics, Inc.$105K
What the payments were for
- Consulting fees$5,20015%
- Speaking & faculty fees$24,00070%
- Travel & lodging$4,17712%
- Food & beverage$9753%
- Education$690%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Transmedics, Inc. | 2 | $22,500 |
| United Therapeutics Corporation | 3 | $5,300 |
| Merck | 5 | $2,832 |
| Xvivo Perfusion Inc. | 2 | $1,643 |
| Sanofi-aventis U.S. LLC | 2 | $1,203 |
| Atricure, Inc. | 6 | $398 |
| Edwards Lifesciences | 1 | $175 |
| La Jolla Pharmaceutical Company | 1 | $128 |
| Intuitive Surgical | 1 | $97 |
| Fresenius USA Marketing, Inc. | 1 | $76 |
| Davol Inc. | 2 | $69 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$34,422 in reported general payments places this provider in the 90th percentile of 2,363 surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valganciclovir Hcl | 38 | $8,826 |
| JanuviaSitagliptin Phosphate | 12 | $7,205 |
| Azithromycin | 73 | $803 |
| Entecavir | 11 | $572 |
| Alendronate Sodium | 54 | $339 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 67 | $294 |
| Rosuvastatin Calcium | 26 | $204 |
| Omeprazole | 36 | $159 |
| Prednisone | 12 | $95 |
| Furosemide | 16 | $86 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $2,832 | $7,20512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,363 surgery providers in California.
Other surgery in San Francisco
- Timothy ChuterSan Francisco$8.8M
- Shane BurchSan Francisco$500K
- Charles EichlerSan Francisco$310K
- Michael AlvaradoSan Francisco$201K
- Scott HansenSan Francisco$186K
- Santiago HorganSan Diego$2.8M
- Rock LiuHayward$1.6M
- David LouriePasadena$1.4M
- Andrea PakulaThousand Oaks$1.4M
- Siew-Ming LeeFresno$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.